This Specialized Center of Research will continue to provide a central supporting structure for the efforts of many investigators concerned with the pulmonary problems of cystic fibrosis and provide a forum for integration and cooperation between their individual projects. The primary topic of the SCOR is being addressed by both clinical and basic research projects. The former are attempting to find better means of patient care and more sensitive indicators of disease progression while the latter are studying the pathologic mechanisms of lung injury and the basic metabolic defect. The specific goals of the individual projects are: -To use a centralized patient data base and analysis system to coordinate patient care and research studies. -To demonstrate the feasibility and medical effectiveness of using automated analysis of home measurements for improving clinical care. -To continue the evolution of a new pulmonary function test for patients of all ages and to use this test to follow normal lung development in young children and disease progression in CF patients. -To investigate the structure and function of mucopolysaccharide molecules in bronchial mucus. -To evaluate a possible mechanism of CF lung destruction by pulmonary macrophages and continue investigations of their metabolic, structural, and phagocytic properties. -To expand upon observations of enhanced metabolic activities of CF monocytes. -To extend the knowledge of the deranged NADH dehydrogenase found in mitochondria from CF subjects as a probably basic defect in CF cells and investigate the possibility of a prenatal test for CF.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Specialized Center (P50)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
Schools of Medicine
United States
Zip Code
Patterson, J M; Budd, J; Goetz, D et al. (1993) Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics 91:383-9
Rao, G H; Fareed, J; White, J G (1991) Influence of heparins on inositol 1,4,5-trisphosphate-induced calcium mobilization in permeabilized human platelets. Biochem Med Metab Biol 45:171-80
Rao, G H; Wilson, R F; White, C W et al. (1991) Influence of thrombolytic agents on human platelet function. Thromb Res 62:319-34
Warwick, W J; Hansen, L G; Werness, M E (1990) Quantification of chloride in sweat with the Cystic Fibrosis Indicator System. Clin Chem 36:96-8
Slagle, J R; Finkelstein, S M; Leung, L A et al. (1989) Monitor: an expert system that validates and interprets time-dependent partial data based on a cystic fibrosis home monitoring program. IEEE Trans Biomed Eng 36:552-8
Brown-Ewing, L J; Finkelstein, S M; Budd, J R et al. (1988) A rule for the early detection of chronic changes in cystic fibrosis patient status. J Clin Epidemiol 41:915-22
Finkelstein, S M; Wielinski, C L; Elliott, G R et al. (1988) Diabetes mellitus associated with cystic fibrosis. J Pediatr 112:373-7
Brown-Ewing, L J; Finkelstein, S M; Budd, J R et al. (1988) Implementation of a home-based program for early detection of clinical deterioration in cystic fibrosis. Med Instrum 22:240-6
Budd, J R; Warwick, W J; Wielinski, C L et al. (1988) A medical information relational database system (MIRDS). Comput Biomed Res 21:419-33
Shapiro, B L; Lam, L F (1987) Intracellular calcium in cystic fibrosis heterozygotes. Life Sci 40:2361-6

Showing the most recent 10 out of 23 publications